Mary Kom wins historic sixth World Championships gold

Mar 16: With COVID-19 outbreak killing over 5,400 people globally, former Pakistan cricketer Shoaib Akhtar has lashed out at those responsible for making the coronavirus infect humans and blamed China solely for the outbreak.

"I don't understand why you have to eat things like bats, drink their blood and urine and spread some virus across the globe...I'm talking about the Chinese people. They have put the world at stake. I really don't understand how you can eat bats, dogs, and cats. I'm really angry," Akhtar said in a video posted on his Youtube channel.

"The whole world is at risk now. The tourism industry has been hit, the economy is badly affected and the whole world is going towards a lockdown.

"I'm not against the people of China but I'm against the law of animals. I understand this may be your culture but this is not benefitting you now, it is killing humanity. I'm not saying you boycott the Chinese but there has to be some law. You cannot go on and eat anything and everything," he added.

Coronavirus, which originated in China's Wuhan city, has so far spread to more than 100 countries, infecting over 1,30,000 people.

In Pakistan, the number of positive cases reached 28 on Saturday.

Many sporting events, including the Indian Premier League (IPL) and Pakistan Super League (PSL), have been affected by the disease which has now been declared a pandemic by the World Health Organisation (WHO).

While the IPL 2020, which was originally scheduled to start from March 29, has been postponed till April 15, the playoff stage of PSL has been curtailed and will be played behind closed doors.

"The biggest reason for anger is PSL...Cricket returned to Pakistan after so many years, the PSL was happening in our country for the first time now even that is at risk. The foreign players are leaving, it will take place behind closed doors," said Akhtar.

The total number of confirmed coronavirus cases across India has crossed 80 while two people have lost their lives due to the deadly disease. But Akhtar did not have the information and added: "God forbid the virus doesn't reach India. There are around 130 crore people there. I've been in touch with my friends in India and wishing them well."

In PSL, there will be no playoffs and the top four teams will now play semi-finals and then the final on March 17 and 18. The final was originally scheduled to be held on March 22.

"I've also heard that IPL has been postponed till April 15. The hotel industries, travel industries, broadcasters everything will incur losses because of this," he said.

The former Pakistan pacer also called on the world authorities to come out with a new animal protection law so that such diseases don't resurface in the future.

May 6: They have similar impact on their teams but Virat Kohli is driven by sheer passion to subdue the rivals while Steve Smith just enjoys batting, says Australia opener David Warner.

India skipper Kohli and top Australian batsman Smith are arguably the top two cricketers of the current era. They achieve new milestones consistently, invoking debates, who is better between them.

"Virat's passion and drive to score runs is different to what Steve's would be," Warner said while speaking to Harsha Bhogle on 'Cricbuzz in Conversation'.

"Steve is going out there for a hit in the middle, that's how he sees things. He's hitting them out in the middle, he's having fun, he's enjoying himself, just does not want to get out."

Warner feels, while Kohli is batting he is aware that if he sticks around the middle his team will be on top of the proceedings.

"Virat obviously doesn't want to get out but he knows if he spends a certain amount of time out there, he's going to score plenty of runs at a rapid rate. He's going to get on top of you. That allows the guys coming in, especially in the Indian team you've got a lot of players who can be flamboyant as well."

The Australian opener added that both men are mentally strong and a good knock by them boosts the morale of the entire team.

"When it comes to cricket, they both have got the mental strength, the mental capacity to score runs. They both love spending time in the middle.

"They stabilise, they boost morale - if they score runs, everyone else's moral is up. If they are out cheaply you almost sense that on the field that everyone is (down on morale and thinking) 'now we all have to step up'. It's a very bizarre situation," he added.

Asked about the similarities between himself and Kohli, who are both live wires on the field, Warner said the passion to do better than the opponent keeps him going.

"I can't speak for Virat, obviously, but it's almost like we got this thing in us when we go (out to the middle) we need to prove people wrong, prove someone wrong."

"If you're in that contest, and if I'm going at him for example, you're thinking, 'Alright, I'm going to score more runs than him, I'm going to take a quick single on him'. You are trying to better that person in that game. That's where the passion comes from."

Warner also explained how he breaks down a match into smaller competitions.

"Obviously you want to win the game but you almost break it down to: If I can score more runs than Virat, or if Pujara scores more runs than Steve Smith, you have these little contests and that's how you try to narrow the game in the sense that if we do these little things, we can be ahead of the game or we can be behind the game.

"The passion is driven by...I know my sense - one, the will to win and two, wanting to do better than that person in the opposition," said Warner.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.